Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-10-21 16:52 | 2015-10-20 | UMH | UMH PROPERTIES, INC. | MONMOUTH REAL ESTATE INVESTMENT CORP | Other | Real Estate Investment Trusts | BUY | $25.00 | 100,000 | $2,500,000 | 100,000 | +100.0% |
| 2015-10-21 23:40 | 2015-10-19 | ISRL | N/A | Naphtha Holding, LTD | 10% owner | Other | BUY | $120.00 | 16,000 | $1,920,000 | 1,938,549 | +0.8% |
| 2015-10-21 23:18 | 2015-10-19 | WYNN | WYNN RESORTS LTD | IRANI RAY R | Director | Hotels & Motels | BUY | $67.99 | 40,000 | $2,719,644 | 46,951 | +575.5% |
| 2015-10-22 01:55 | 2015-10-19 | ALIM | N/A | Flynn James E | 10% owner, Other | Other | BUY | $2.97 | 390,040 | $1,159,862 | 366,218 | +100.0% |
| 2015-10-21 00:03 | 2015-10-16 | CATS | Ontrak, Inc. | PEIZER TERREN S | Director, Officer, 10% owner - Chairman & CEO | Services-Misc Health & Allied Services, NEC | BUY | $0.30 | 5,410,000 | $1,623,000 | 38,358,250 | +16.4% |
| 2015-10-20 21:18 | 2015-10-19 | PLX | Protalix BioTherapeutics, Inc. | Camber Capital Management LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $1.00 | 4,000,423 | $4,000,423 | 13,275,000 | +43.1% |
| 2015-10-15 22:17 | 2015-10-15 | IBAL | N/A | Avis Industrial Corp | Director, 10% owner | Other | BUY | $2,130.00 | 852 | $1,814,760 | 1,084,501 | +0.1% |
| 2015-10-15 23:53 | 2015-10-13 | BNED | Barnes & Noble Education, Inc. | ABRAMS CAPITAL MANAGEMENT, L.P. | 10% owner | Retail-Miscellaneous Shopping Goods Stores | BUY | $12.42 | 104,866 | $1,302,834 | 7,526,984 | +1.4% |
| 2015-10-14 21:40 | 2015-10-13 | ACRS | Aclaris Therapeutics Inc. | FMR LLC | 10% owner, Other | Pharmaceutical Preparations | BUY | $11.00 | 335,455 | $3,690,005 | 3,804,279 | +9.7% |
| 2015-10-14 19:34 | 2015-10-14 | CTMX | CytomX Therapeutics, Inc. | Flynn James E | 10% owner, Other | Pharmaceutical Preparations | BUY | $12.00 | 625,000 | $7,500,000 | 275,000 | +100.0% |
| 2015-10-13 23:18 | 2015-10-08 | ASYS | AMTECH SYSTEMS INC | PITON CAPITAL PARTNERS LLC | 10% owner | Special Industry Machinery, NEC | BUY | $4.92 | 305,000 | $1,500,966 | 445,000 | +217.9% |
| 2015-10-13 21:21 | 2015-10-13 | REPR | KORU Medical Systems, Inc. | Radin Arthur J | Director | Surgical & Medical Instruments & Apparatus | BUY | $16,800.00 | 40,000 | $672,000,000 | 100,600 | +66.0% |
| 2015-10-13 23:37 | - | NBIO | Nascent Biotech Inc. | Carrick Sean | Director, Officer - Principal Executive Officer | Pharmaceutical Preparations | BUY | $1.45 | 1,030,401 | $1,492,227 | 1,227,601 | +522.5% |
| 2015-10-13 23:39 | 2015-10-08 | DM | N/A | DOMINION RESOURCES INC /VA/ | Director, 10% owner | Other | BUY | $29.42 | 87,975 | $2,588,620 | 49,487,857 | +0.2% |
| 2015-10-13 20:26 | 2015-10-13 | ACRS | Aclaris Therapeutics Inc. | Mehra Anand | Director, 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 409,090 | $4,499,990 | 2,289,480 | +21.8% |
| 2015-10-13 20:29 | 2015-10-13 | ACRS | Aclaris Therapeutics Inc. | VIVO VENTURES VII, LLC | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 454,545 | $4,999,995 | 89,400 | +100.0% |
| 2015-10-13 20:30 | 2015-10-13 | ACRS | Aclaris Therapeutics Inc. | CHA ALBERT | Director | Pharmaceutical Preparations | BUY | $11.00 | 454,545 | $4,999,995 | 4,191,397 | +12.2% |
| 2015-10-13 16:34 | 2015-10-07 | ACRS | Aclaris Therapeutics Inc. | RA CAPITAL MANAGEMENT, LLC | 10% owner | Pharmaceutical Preparations | BUY | $10.86 | 2,237,130 | $24,289,863 | 2,237,130 | +100.0% |
| 2015-10-14 00:24 | 2015-09-18 | EVRI | N/A | Mast Capital Management, LLC | 10% owner | Other | BUY | $5.35 | 630,000 | $3,369,555 | 911,991 | +223.4% |
| 2015-10-13 20:26 | 2015-10-13 | ACRS | Aclaris Therapeutics Inc. | Sofinnova Venture Partners VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $11.00 | 409,090 | $4,499,990 | 2,289,480 | +21.8% |
| 2015-10-14 03:35 | 2015-04-27 | ABTL | N/A | Klose de Ojeda John Peter | 10% owner | Other | BUY | $4.65 | 708,129 | $3,292,800 | 708,129 | +100.0% |
| 2015-10-14 03:34 | 2015-04-27 | ABTL | N/A | Aitkenhead Castillo Richard | 10% owner | Other | BUY | $4.65 | 708,129 | $3,292,800 | 708,129 | +100.0% |
| 2015-10-14 03:33 | 2015-04-27 | ABTL | N/A | PF Auto, Inc. | 10% owner | Other | BUY | $4.65 | 700,752 | $3,258,497 | 700,752 | +100.0% |
| 2015-10-10 00:12 | 2015-10-09 | HCHC | INNOVATE Corp. | FALCONE PHILIP | Director, Officer - CEO, Chairman & President | Fabricated Structural Metal Products | BUY | $7.50 | 540,000 | $4,050,000 | 1,423,578 | +61.1% |
| 2015-10-08 23:24 | 2015-10-06 | DM | N/A | DOMINION RESOURCES INC /VA/ | Director, 10% owner | Other | BUY | $27.74 | 129,628 | $3,595,712 | 49,399,882 | +0.3% |
| 2015-10-08 23:11 | 2015-10-06 | EDGE | PDS Biotechnology Corp | Hove Anders D | Director | Pharmaceutical Preparations | BUY | $11.00 | 450,000 | $4,950,000 | 2,021,917 | +28.6% |
| 2015-10-08 23:14 | 2015-10-06 | EDGE | PDS Biotechnology Corp | HEALY JAMES | Director | Pharmaceutical Preparations | BUY | $11.00 | 450,000 | $4,950,000 | 2,257,703 | +24.9% |
| 2015-10-08 19:00 | 2015-10-06 | APPF | Appfolio Inc. | OBERNDORF WILLIAM E | 10% owner | Services-Prepackaged Software | BUY | $16.50 | 666,667 | $11,000,006 | 1,135,567 | +142.2% |
| 2015-10-09 00:50 | 2015-10-06 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $472.33 | 11,040 | $5,214,519 | 23,108,570 | +0.0% |
| 2015-10-09 00:45 | 2015-10-06 | REGN | REGENERON PHARMACEUTICALS, INC. | Sanofi | 10% owner | Pharmaceutical Preparations | BUY | $459.71 | 80,538 | $37,024,196 | 23,097,530 | +0.3% |
| 2015-10-09 01:46 | 2015-10-06 | SQNM | N/A | Camber Capital Management LLC | 10% owner | Other | BUY | $1.96 | 1,650,090 | $3,241,932 | 15,400,000 | +12.0% |
| 2015-10-09 02:41 | 2015-10-06 | NYRT | N/A | ROWAN MARC J | Director | Other | BUY | $10.61 | 234,948 | $2,492,046 | 234,948 | +100.0% |
| 2015-10-07 22:36 | 2015-10-05 | TLCC | Twinlab Consolidated Holdings, Inc. | GOLISANO B THOMAS | 10% owner | Medicinal Chemicals & Botanical Products | BUY | $0.28 | 88,711,241 | $24,839,147 | 88,711,241 | +100.0% |
| 2015-10-08 00:27 | 2015-08-12 | N-A | Crescent Capital BDC, Inc. | Fidelity & Guaranty Life | 10% owner | Other | BUY | $19.99 | 746,390 | $14,921,838 | 1,226,021 | +155.6% |
| 2015-10-08 00:42 | 2015-10-06 | MIRN | SYNLOGIC, INC. | PFIZER INC | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 714,285 | $4,999,995 | 2,253,509 | +46.4% |
| 2015-10-07 17:27 | 2015-10-05 | FOLD | AMICUS THERAPEUTICS, INC. | PERCEPTIVE ADVISORS LLC | 10% owner | Pharmaceutical Preparations | BUY | $6.71 | 750,000 | $5,031,525 | 15,189,444 | +5.2% |
| 2015-10-07 23:31 | 2015-10-07 | TBPH | Theravance Biopharma, Inc. | GLAXOSMITHKLINE PLC | 10% owner | Pharmaceutical Preparations | BUY | $607,543.62 | 44,574 | $27,080,649,318 | 8,343,792 | +0.5% |
| 2015-10-06 23:18 | 2015-10-02 | DM | N/A | DOMINION RESOURCES INC /VA/ | Director, 10% owner | Other | BUY | $27.66 | 52,075 | $1,440,332 | 49,270,254 | +0.1% |
| 2015-10-06 23:07 | 2015-10-02 | CAPL | CrossAmerica Partners LP | CST BRANDS, INC. | 10% owner | Wholesale-Petroleum & Petroleum Products (No Bulk Stations) | BUY | $24.68 | 43,000 | $1,061,042 | 5,517,682 | +0.8% |
| 2015-10-06 22:16 | 2015-10-06 | MIRN | SYNLOGIC, INC. | Sonsini Peter W. | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:13 | 2015-10-06 | MIRN | SYNLOGIC, INC. | New Enterprise Associates 14, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:12 | 2015-10-06 | MIRN | SYNLOGIC, INC. | Florence Anthony A. Jr. | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:17 | 2015-10-06 | MIRN | SYNLOGIC, INC. | Viswanathan Ravi | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:18 | 2015-10-06 | MIRN | SYNLOGIC, INC. | Weller Harry R | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:10 | 2015-10-06 | MIRN | SYNLOGIC, INC. | BASKETT FOREST | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:14 | 2015-10-06 | MIRN | SYNLOGIC, INC. | KOLLURI KRISHNA KITTU | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 23:09 | 2015-10-06 | MIRN | SYNLOGIC, INC. | Sofinnova Venture Partners VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,974,811 | +40.5% |
| 2015-10-06 22:16 | 2015-10-06 | MIRN | SYNLOGIC, INC. | SANDELL SCOTT D | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:13 | 2015-10-06 | MIRN | SYNLOGIC, INC. | KERINS PATRICK J | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
| 2015-10-06 22:15 | 2015-10-06 | MIRN | SYNLOGIC, INC. | MOTT DAVID M | 10% owner | Pharmaceutical Preparations | BUY | $7.00 | 857,142 | $5,999,994 | 2,971,517 | +40.5% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.